Glenmark gets USFDA nod for pneumonia treatment drug

New Delhi: Glenmark Pharmaceuticals Thursday said it has received final approval from the US health regulator for Atovaquone, used for prevention and treatment of a type of pneumonia. Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Atovaquone Oral Suspension USP in the strength of 750 mg/5 mL,” the company said in a BSE filing.

The approved drug is a generic version of GlaxoSmithKline’s Mepron Oral Suspension of similar strength.

Quoting IQVIA sales data, Glenmark said, Mepron Oral Suspension market achieved annual sales of approximately USD 119.1 million.

The company’s current portfolio consists of 144 products authorised for distribution in the US marketplace and 55 abbreviated new drug applications (ANDAs) pending approval with the USFDA.

The company’s shares were trading at Rs 633.10 apiece, down 1.26 per cent, on the BSE.

  • Related Posts

    3-month relief: Final call for 10,000 pharmacists to renew registration

    At least 70,000 pharmacists are registered in Haryana; of these, about 10,000 — whose registrations expired on December 31, 2020, — have not yet renewed The Haryana State Pharmacy Council…

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules

    Marksans Pharma Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of Benzonatate capsules indicated for treatment of persistent cough, bronchitis,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    3-month relief: Final call for 10,000 pharmacists to renew registration

    3-month relief: Final call for 10,000 pharmacists to renew registration

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules

    Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’

    Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’

    Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

    Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices